ArticleMaterials (Basel, Switzerland)2026
Effect of Chemical Attack Inhibitor Dosage on the Performance of Self-Compacting Concrete and Its Micro-Mechanisms.
Article in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Self-compacting concrete (SCC) is widely adopted in complex structural engineering due to its excellent flowability and filling capacity. However, in harsh corrosive environments, its complex internal pore structure can easily serve as a preferential pathway for the transport of aggressive media, leading to durability deterioration. This study systematically investigates the effects of chemical attack inhibitor (CAI) on the workability, mechanical properties, sulfate attack resistance, and chloride ion penetration resistance of SCC. The micro-mechanisms governing pore structure evolution are elucidated using low-field nuclear magnetic resonance (LF-NMR) and X-ray computed tomography (X-CT). At a CAI dosage of 2%, the fresh SCC exhibits a slump of 260 mm and slump flow of 720 mm, indicating excellent filling and gap-passing abilities. Meanwhile, the compressive strengths at 3 d, 7 d, and 28 d remain at a high level. After 120 sulfate wet-dry cycles, the strength loss rate is only 8.4%, with an erosion resistance coefficient exceeding 90%. In addition, the resistance to chloride ion penetration is significantly improved, with an electric flux of only 1331 C, which is considerably lower than that of the control group (1637 C). At the optimal dosage of CAI, the concrete exhibits a dense and uniform internal structure devoid of macroscopic defects or cracks, with minimized porosity, thus synergistically enhancing the resistance to sulfate attack and chloride attack. On the contrary, further increasing the CAI dosage markedly intensifies the inhibitory effect of organic components on cement hydration, leading to increased early-age defects and enhanced pore connectivity. Thus, an appropriate amount of CAI can effectively improve the overall performance of SCC, providing a solid experimental basis and theoretical support for its engineering application in harsh corrosive environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.